His practice focuses on intellectual property litigation and counseling, including patent infringement and trade secret matters.
In his practice, Mr. Ling has represented clients across a range of industries, spanning biopharmaceuticals, wireless communications, and computer technologies. He has experience handling patent and trade secret litigation on behalf of both plaintiffs and defendants, including at trial. In 2019, he represented Amgen in obtaining a favorable settlement on the eve of trial, including a multi-year royalty, resolving a trade secrets dispute brought against Coherus BioSciences involving the oncology drug Neulasta®. Other experiences include advising clients on due diligence regarding intellectual property rights and representing amicus curiae at the U.S. Supreme Court.
Mr. Ling joined the firm after clerking with Chief Judge Sharon Prost of the U.S. Court of Appeals for the Federal Circuit. Prior to his clerkship, he was an associate in the New York office of an international law firm, where he focused on intellectual property litigation. He also clerked for Judge Kent A. Jordan of the U.S. Court of Appeals for the Third Circuit and Judge Sue L. Robinson of the U.S. District Court for the District of Delaware. During law school, he served as a legal writing instructor.
Outside of his practice, Mr. Ling has authored articles on legal topics for Intellectual Property Magazine and the American Bar Association. In 2017, he spoke at “Patent Disputes Forum South” hosted by the Daily Journal.
Mr. Ling speaks Mandarin Chinese.